Evidence map›Paper›PMID 33228666›Full record

ArticleMalaria journal2020

Building momentum for malaria vaccine research and development: key considerations.

Chetan E Chitnis, David Schellenberg, Johan Vekemans, Edwin J Asturias, Philip Bejon, Katharine A Collins, Brendan S Crabb, Socrates Herrera, Miriam Laufer, N Regina Rabinovich and 6 more

Abstract readLetter
In one paragraph

Article in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. RTS,S today and tomorrow's science.Cell host & microbe · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Chetan E ChitnisInstitut Pasteur, Paris, France.
David SchellenbergWorld Health Organization, Geneva, Switzerland. schellenbergd@who.int.ORCID http://orcid.org/0000-0001-8222-0186
Johan VekemansWorld Health Organization, Geneva, Switzerland.
Edwin J AsturiasUniversity of Colorado School of Medicine and Colorado School of Public Health, Denver, USA.
Philip BejonKEMRI-Wellcome Trust Research Programme, Kilifi, Kenya.
Katharine A CollinsDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.
Brendan S CrabbBurnet Institute, Melbourne, Australia.
Socrates HerreraConsorcio Para La Investigacion Cientifica, Cali, Colombia.
Miriam LauferUniversity of Maryland School of Medicine, Baltimore, USA.
N Regina RabinovichIS Global, Barcelona, Spain.
Meta RoestenbergLeiden University Medical Center, Leiden, The Netherlands.
Adelaide ShearleyJohn Snow Inc, Research & Training Institute, Boston, USA.
Halidou TintoInstitut de Recherche en Sciences de La Santé, Ouagadougou, Burkina Faso.
Marian WentworthManagement Sciences for Health, Arlington, USA.
Kate O'BrienWorld Health Organization, Geneva, Switzerland.
Pedro AlonsoWorld Health Organization, Geneva, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

To maintain momentum towards improved malaria control and elimination, a vaccine would be a key addition to the intervention toolkit. Two approaches are recommended: (1) promote the development and short to medium term deployment of first generation vaccine candidates and (2) support innovation and discovery to identify and develop highly effective, long-lasting and affordable next generation malaria vaccines.

Indexed as

Biomedical ResearchMalaria VaccinesDrug DiscoveryMalaria VaccinesControlEliminationMalariaResearch and developmentVaccine

Identifiers

PMID33228666
PMCPMC7682132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.